Clinical Trial Update: Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy [Phase 2]

View source ↗

Summary

An ongoing Phase 2 trial is evaluating chemotherapy and immunotherapy with thoracic radiotherapy in extensive-stage small-cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Snippet

Sponsor: Trans Tasman Radiation Oncology Group | Conditions: Extensive-Stage Small-Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING